The benchmark for assessing quality of long-term glycemic control and adjustment of
therapy is currently glycated hemoglobin (HbA1c). Despite its importance as an indicator for …

Glycemic variability (GV) appears today as an integral component of glucose homeostasis
for the management of type 2 diabetes (T2D). This review aims at investigating the use and …

Background: Despite the centrality of nutrition in the management of type 1 diabetes, the
association of diet quality and macronutrient distribution with glycemic control is ambiguous …

The practicing physician is faced with the task of interpreting> 2 dozen indices of quality of
glycemic control and glycemic variability. It would be desirable to have reference data from …

Objective: To report the impact of continuous glucose monitoring (CGM) on glycemic
variability (GV) indices, factors predictive of change, and to correlate variability with …

Background The aim of this study was to determine the efficacy of real‐time continuous
glucose monitoring in T1D patients treated with insulin pump therapy or multiple daily insulin …

The advancement of technology in the field of glycemic control has led to the widespread
use of continuous glucose monitoring (CGM), which can be nowadays obtained from …

Currently, most reliable and commercialized artificial pancreas systems for type 1 diabetes
are hybrid closed-loop systems, which require the user to announce every meal and its size …

The introduction of continuous glucose monitoring inaugurated a new era in clinical practice
by shifting the characterization of glycemic control from HbA1c to novel metrics. The one that …

Background: Time-restricted eating (TRE), limiting daily dietary intake to a consistent 8 to 10
hours without mandating calorie reduction, may provide cardiometabolic benefits. Objective …